Gadolinium

Arkansas Gadolinium Attorneys

Gadolinium is a silvery-white contrast agent injected into patients who undergo magnetic resonance imaging (MRI) to expose abnormal tissue. After injected, gadolinium accumulates around aberrant cell growths or tumors, helping doctors more effectively diagnose and treat patients. However, some patients who are exposed to gadolinium have experienced devastating and sometimes deadly side effects, specifically those who already suffer from kidney disease or dysfunction.

Adverse Side Effects of Gadolinium Injections

Drug Recall AttorneysThe adverse side effects associated with gadolinium began surfacing in 1997. By 2006, the contrast agent was connected to a rare and serious disease called Nephrogenic Systemic Fibrosis (NSF), which attacks the fibrosis of joints of your eyes, skin and internal organs.

Doctors found that many patients who were suffering from NSF after being injected with gadolinium had a predisposed kidney condition. Those with impaired kidney function are not able to effectively remove waste from their bloodstream, so toxic reactions to gadolinium were more likely to occur.

Anyone who has suffered from NSF after undergoing a gadolinium injection should speak to an Arkansas gadolinium attorney immediately.

About NSF

Patients who experience NSF may develop patches of hardened skin or thickened skin with fibrotic nodules. Areas of thick, tight skin can severely limit your range of motion, resulting in falls and broken bones. Those suffering from NSF may also develop a thickening of their organs, which can be extremely dangerous. This can cause difficulty breathing and can result in organ paralysis and even death.

The FDA Intervenes

The Food and Drug Administration (FDA) has requested that the drug manufacturer include a “black box” warning on all gadolinium-based contrast agents used in MRIs.

This warning would state that patients with severe kidney insufficiency who have a gadolinium-based agent injected are at risk for debilitating the potentially-fatal disease, NSF.

Five gadolinium-based contrast agents have been approved for use in the United States:

  • OptiMARK (gadoversetamide)
  • Magnevist (gadopentetate dimeglumine)
  • Ominiscan (gadodiamide)
  • MultiHance (gadobenate dimeglumine)
  • Prohance (gadoteridol)

To date, all but Prohance have been linked to NSF.

Importance of Proper Screenings First

Before you have a gadolinium-based contrast agent injected, it is imperative that you are screened for kidney problems. There have not been any reports to-date of NSF occurring in patients with normal kidney function, or even those with mild-to-moderate kidney insufficiency.

If you are an Arkansas resident who was injected with gadolinium and are now suffering from NSF symptoms, please contact our Arkansas gadolinium attorneys at 1-877-LOSS-RECOVER (567-7732) so that our lawyers can fight to get you the money you deserve.